Louis Delhaye

5PUBLICATIONS
46CO-AUTHORS
Genome structure and regulationCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTe mana motuhake o ngā raraunga Māori (Māori data sovereignty)Ngā pūnaha whakahaere mōhiohio me te mātauranga o te Māori (Māori information and knowledge management systems)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 15, 2026
Widespread DNA off-targeting confounds RNA chromatin occupancy studies.

|Sep 24, 2025
A drug-diet combination could improve childhood cancer treatment.

Frank Speleman, Louis Delhaye

|Jul 20, 2022
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition.

Carolina Nunes, Lisa Depestel, Liselot Mus

|Nov 16, 2021
Correction to: The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival.

Shanna Dewaele, Louis Delhaye, Boel De Paepe

|Sep 11, 2021
The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival.

Shanna Dewaele, Louis Delhaye, Boel De Paepe

Pageof 1

Frequent Collaborators

3 joint publications

Pieter Mestdagh

3 joint publications

Sven Eyckerman

2 joint publications

Shanna Dewaele

2 joint publications

Boel De Paepe